Cambria Investment Management’s Merck MRK Stock Holding History

Cambria Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	11,069 +3,799	+52%	+$445K	0.07%	240
2026 Q1	$875K	Buy	7,270 +1,246	+21%	+$144K	0.05%	254
2025 Q4	$634K	Buy	+6,024	New	+$565K	0.04%	341
2019 Q4	–	Sell	-60,103	Closed	-$4.83M	–	215
2019 Q3	$4.83M	Sell	60,103 -729	-1%	-$58.4K	0.72%	59
2019 Q2	$4.87M	Buy	60,832 +826	+1%	+$63.2K	0.75%	51
2019 Q1	$4.76M	Buy	60,006 +964	+2%	+$72.1K	0.74%	45
2018 Q4	$4.3M	Sell	59,042 -10,734	-15%	-$758K	0.73%	42
2018 Q3	$4.72M	Sell	69,776 -1,729	-2%	-$110K	0.69%	40
2018 Q2	$4.23M	Sell	71,505 -12,328	-15%	-$695K	0.63%	67
2018 Q1	$4.36M	Sell	83,833 -23,241	-22%	-$1.26M	0.63%	73
2017 Q4	$5.75M	Buy	107,074 +24,366	+29%	+$1.35M	0.8%	66
2017 Q3	$5.05M	Buy	82,708 +5,271	+7%	+$320K	0.78%	60
2017 Q2	$4.74M	Buy	+77,437	New	+$4.71M	1.02%	32

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cambria Investment Management's MRK Position: Q2 2026 in Review

Cambria Investment Management increased its Merck (MRK) stake by 52% in Q2 2026, buying an estimated $445K and bringing the position to 11,069 shares worth $1.42M. The position accounts for 0.07% of the portfolio, ranked #240.

Cambria Investment Management first reported a position in MRK in Q2 2017 and has held it in 13 quarters since. The position peaked at $5.75M in Q4 2017. 3,853 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Cambria Investment Management held 11,069 shares of Merck worth $1.42M as of Q2 2026.
Cambria Investment Management bought 3,799 Merck shares in Q2 2026, an estimated $445K.
Merck made up 0.07% of Cambria Investment Management's portfolio in Q2 2026, its #240 holding.
Cambria Investment Management first reported a position in Merck in Q2 2017 and has held it in 13 quarters since.
Cambria Investment Management's Merck position peaked at $5.75M in Q4 2017.
3,853 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.